Carisoprodol Tablets, Usp, 350 Mg Tablet
NDC Package 71335-3018-1

11-digit billing NDC: 71335301801 · Billing unit: EA · 1000 EA per package
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Carisoprodol Tablets, Usp, 350 Mg (carisoprodol) tablets is carisoprodol Tablets, USP are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.Limitation of UseCarisoprodol Tablets, USP should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [ see Dosage and Administration (2)]. This formulation utilizes a tablet delivery system. Marketed by Bryant Ranch Prepack, this product is identified by NDC 71335-3018 and is authorized under FDA application ANDA211789.

Identification & Billing

NDC Package Code
71335-3018-1
Package Description
1000 TABLET in 1 BOTTLE
Product Code
71335-3018
11-Digit Billing Format
71335301801
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1000 EA
RxNorm Crosswalk
RxCUI: 197446 - carisoprodol 350 MG Oral Tablet

Clinical Specifications

Proprietary Name
Carisoprodol Tablets, Usp, 350 Mg
Non-Proprietary Name
Carisoprodol
Substance Name
Carisoprodol
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CARISOPRODOL 350 mg/1
Pharmacologic Class
Usage Information
Carisoprodol Tablets, USP are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.Limitation of UseCarisoprodol Tablets, USP should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [ see Dosage and Administration (2)].
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
Bryant Ranch Prepack
Product Type
Human Prescription Drug
FDA Application #
ANDA211789
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-11-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71335-3018-1 identifies a specific commercial package of 1000 tablet in 1 bottle of Carisoprodol Tablets, Usp, 350 Mg, a human prescription drug labeled by Bryant Ranch Prepack. This product is billed for "EA" each discreet unit and contains an estimated amount of 1000 billable units per package. This tablet is formulated for oral use and contains carisoprodol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bryant Ranch Prepack on June 11, 2025. The current certification is valid through December 31, 2026.

How is this Bryant Ranch Prepack product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71335301801. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71335-3018-1
11-Digit CMS (5-4-2)
71335-3018-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.